TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $718,136,000 | -24.2% | 39,458 | -25.7% | 0.51% | -17.2% |
| Q3 2020 | $947,161,000 | -0.5% | 53,092 | 0.0% | 0.62% | -36.7% |
| Q2 2020 | $951,940,000 | +18.1% | 53,092 | 0.0% | 0.98% | -37.6% |
| Q1 2020 | $805,937,000 | -23.1% | 53,092 | 0.0% | 1.57% | +22.1% |
| Q4 2019 | $1,047,505,000 | -2.8% | 53,092 | -15.2% | 1.29% | +55.6% |
| Q3 2019 | $1,077,374,000 | -78.3% | 62,638 | -77.6% | 0.83% | -62.4% |
| Q2 2019 | $4,956,000,000 | -43.5% | 280,000 | -34.9% | 2.20% | -48.4% |
| Q1 2019 | $8,766,617,000 | -44.2% | 430,369 | -53.9% | 4.26% | -53.7% |
| Q4 2018 | $15,700,898,000 | – | 933,466 | – | 9.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |